Product: CUROSURF (poractant alfa), 240 mg, Intratracheal Suspension, 3L Single-dose-Vial, Rx only, Chiesi USA, Inc, Cary, NC 27518, NDC 10122-510-03.
Reason for recall: Lack of Assurance of Sterility
Recall initiated: 20260317
Status: Ongoing
Classification: Class II
Recall type: Voluntary: Firm initiated